Per Ola Freskgaard

Title: Per Ola Freskgaard: Innovator in Protein C Conjugates

Introduction

Per Ola Freskgaard is a notable inventor based in Vellinge, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of novel protein C conjugates. With a total of two patents to his name, Freskgaard's work has the potential to impact the treatment of various diseases.

Latest Patents

Freskgaard's latest patents focus on protein C or activated protein C-like molecules. These inventions relate to novel conjugates between polypeptide variants of protein C and non-polypeptide moieties, such as PEG or sugar moieties. The innovations provide protein C conjugates that exhibit increased resistance to inactivation by human plasma and α-antitrypsin. As a result, these conjugates have an enhanced in vivo half-life. Preferred examples include those with at least one additional in vivo N-glycosylation site introduced. The conjugates are particularly useful for treating a variety of diseases, including septic shock.

Career Highlights

Throughout his career, Freskgaard has worked with prominent companies such as Maxygen Aps and Maxygen Holdings Ltd. His experience in these organizations has contributed to his expertise in the field of biochemistry and patent development.

Collaborations

Freskgaard has collaborated with notable colleagues, including Kim Vilbour Andersen and Anders Pedersen. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Per Ola Freskgaard is a distinguished inventor whose work on protein C conjugates holds promise for advancing medical treatments. His contributions to the field are noteworthy and reflect his commitment to innovation in biochemistry.